Schott Pharma IPO's investor demand exceeds deal size -bookrunners
BERLIN (Reuters) -Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, including the greenshoe option, banks told investors on Tuesday, an hour after the start of the subscription period. Reuters reported in early September that Schott was targeting proceeds of at least 800 million euros in the deal, making it Germany's largest IPO so far this year.